Fenfluramine in the treatment of obesity.
D000328:Adult; D001067:Appetite Depressants; D001835:Body Weight; D002986:Clinical Trials as Topic; D003248:Constipation / Q000139:chemically induced; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005260:Female; D005277:Fenfluramine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009765:Obesity / Q000188:drug therapy*; D010919:Placebos; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D001067:Appetite Depressants; D010919:Placebos; D005277:Fenfluramine; D003913:Dextroamphetamine